Provided by Tiger Trade Technology Pte. Ltd.

Veracyte

33.78
-0.9000-2.60%
Volume:431.74K
Turnover:14.55M
Market Cap:2.68B
PE:41.20
High:34.28
Open:33.34
Low:33.11
Close:34.68
52wk High:50.71
52wk Low:22.61
Shares:79.46M
Float Shares:78.23M
Volume Ratio:0.71
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8200
EPS(LYR):0.8200
ROE:5.34%
ROA:2.91%
PB:2.05
PE(LYR):41.20

Loading ...

Veracyte Is Maintained at Buy by Needham

Dow Jones
·
Nov 05, 2025

Veracyte’s Strong Financial Performance and Promising Pipeline Justify Buy Rating

TIPRANKS
·
Nov 05, 2025

Veracyte’s Strong Financial Performance and Growth Prospects Justify Buy Rating and Increased Price Target

TIPRANKS
·
Nov 05, 2025

Stock Track | Veracyte (VCYT) Soars 11.16% Pre-Market on Stellar Q3 Results and Raised 2025 Outlook

Stock Track
·
Nov 05, 2025

Stock Track | Veracyte Soars 11.16% Pre-market on Strong Q3 Results and Raised 2025 Guidance

Stock Track
·
Nov 05, 2025

Stock Track | Veracyte Soars 13.98% on Impressive Q3 Results and Raised Full-Year Guidance

Stock Track
·
Nov 05, 2025

Stock Track | Veracyte Soars 13.98% Following Impressive Q3 Results and Raised 2025 Guidance

Stock Track
·
Nov 05, 2025

Veracyte Reports Strong Q3 2025 Financial Performance

TIPRANKS
·
Nov 05, 2025

Stock Track | Veracyte Soars 5.90% After-Hours on Strong Q3 Results and Raised Guidance

Stock Track
·
Nov 05, 2025

Veracyte Q3 Revenue USD 131.9 Million Vs. IBES Estimate USD 124.6 Million

Reuters
·
Nov 05, 2025

Genomic diagnostics firm Veracyte Q3 revenue beats estimates on higher testings

Reuters
·
Nov 05, 2025

Veracyte reports third quarter revenue of $131.9 million, up 14% year-over-year

Reuters
·
Nov 05, 2025

Veracyte Q3 Adjusted EPS USD 0.51 VS. Ibes Estimate USD 0.12

THOMSON REUTERS
·
Nov 05, 2025

Veracyte Unveils Studies Highlighting Afirma GRID's Potential in Preoperative Thyroid Cancer Prognosis

Reuters
·
Nov 04, 2025

Veracyte Inc expected to post earnings of 13 cents a share - Earnings Preview

Reuters
·
Nov 01, 2025

Is Veracyte’s Recent 9.8% Rally a Sign of More Value in 2025?

Simply Wall St.
·
Oct 26, 2025

Canaccord Genuity Initiates Coverage on Veracyte With Hold Rating, $40 Price Target

MT Newswires Live
·
Oct 20, 2025

Veracyte Initiated at Hold by Canaccord Genuity

Dow Jones
·
Oct 20, 2025

Veracyte initiated with a Hold at Canaccord

TIPRANKS
·
Oct 20, 2025

Veracyte (VCYT): Assessing Valuation After Recent Momentum and Share Price Rebound

Simply Wall St.
·
Oct 18, 2025